$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Drug repurposing: small molecules against Cu(II)–amyloid-β and free radicals

Journal of inorganic biochemistry, v.224, 2021년, pp.111592 -   

Nam, Geewoo (Corresponding author.) ,  Suh, Jong-Min ,  Yi, Yelim ,  Lim, Mi Hee

Abstract AI-Helper 아이콘AI-Helper

Abstract Alzheimer's disease (AD) presents a complex pathology entangling numerous pathological factors, including amyloid-β (Aβ), metal ions, and reactive oxygen species (ROS). Increasing evidence reveals pathological connections among these distinct components in AD. For instance, the a...

Keyword

참고문헌 (54)

  1. Chem. Rev. Savelieff 119 1221 2019 10.1021/acs.chemrev.8b00138 Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the last decade 

  2. Science Hardy 256 184 1992 10.1126/science.1566067 Alzheimer's disease: the amyloid cascade hypothesis 

  3. Science Selkoe 365 540 2019 10.1126/science.aay5188 Early network dysfunction in Alzheimer's disease 

  4. Chem. Rev. Kepp 112 5193 2012 10.1021/cr300009x Bioinorganic chemistry of Alzheimer’s disease 

  5. J. NeuroImmune Pharmacol. Muhammad 14 278 2019 10.1007/s11481-018-9824-3 Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model 

  6. Biochim. Biophys. Acta Mol. Cell Biol. Lipids Naudí 1862 485 2017 10.1016/j.bbalip.2017.02.001 Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system 

  7. Nat. Cell Biol. Herrero-Mendez 11 747 2009 10.1038/ncb1881 The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1 

  8. FEBS Lett. Stefanatos 592 743 2018 10.1002/1873-3468.12902 The role of mitochondrial ROS in the aging brain 

  9. Biochemistry Nam 59 15 2020 10.1021/acs.biochem.9b00775 Synaptic copper, amyloid-β, and neurotransmitters in Alzheimer’s disease 

  10. Chem. Lett. Nam 48 951 2019 10.1246/cl.190281 Intertwined pathologies of amyloid-β and metal ions in Alzheimer’s disease: metal-amyloid-β 

  11. Acc. Chem. Res. Faller 47 2252 2014 10.1021/ar400293h Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles 

  12. Dalton Trans. Atrián-Blasco 46 12750 2017 10.1039/C7DT01344B Mutual interference of Cu and Zn ions in Alzheimer’s disease: perspectives at the molecular level 

  13. Coord. Chem. Rev. Atrián-Blasco 371 38 2018 10.1016/j.ccr.2018.04.007 Cu and Zn coordination to amyloid peptides: from fascinating chemistry to debated pathological relevance 

  14. Coord. Chem. Rev. Zawisza 256 2297 2012 10.1016/j.ccr.2012.03.012 Affinity of copper and zinc ions to proteins and peptides related to neurodegenerative conditions (Aβ, APP, α-synuclein, PrP) 

  15. ACS Chem. Biol. Savelieff 8 856 2013 10.1021/cb400080f Untangling amyloid-β, tau, and metals in Alzheimer's disease 

  16. Angew. Chem. Int. Ed. Zou 40 2274 2001 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5 Cu2+ inhibits the aggregation of amyloid β-peptide(1-42) in vitro 

  17. J. Biol. Chem. Yoshiike 276 32293 2001 10.1074/jbc.M010706200 New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity 

  18. J. Biol. Chem. Pedersen 286 26952 2011 10.1074/jbc.M111.220863 Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-β peptides 

  19. Angew. Chem. Int. Ed. Jun 46 3959 2007 10.1002/anie.200700318 The aggregated state of amyloid-β peptide in vitro depends on Cu2+ ion concentration 

  20. Coord. Chem. Rev. Kepp 351 127 2017 10.1016/j.ccr.2017.05.007 Alzheimer’s disease: how metal ions define β-amyloid function 

  21. Nat. Rev. Drug Discov. Ashburn 3 673 2004 10.1038/nrd1468 Drug repositioning: identifying and developing new uses for existing drugs 

  22. Am. J. Psychiatry Rovner 146 350 1989 10.1176/ajp.146.3.350 Depression and Alzheimer's disease 

  23. Biol. Psychiatry Lyketsos 52 243 2002 10.1016/S0006-3223(02)01348-3 Depression in Alzheimer’s disease: overview and treatment 

  24. Neurol. Ther. Burke 8 325 2019 10.1007/s40120-019-00148-5 Diagnosing and treating depression in patients with Alzheimer’s disease 

  25. J. Neuropsychiatry Clin. Neurosci. Lyketsos 9 556 1997 10.1176/jnp.9.4.556 Major and minor depression in Alzheimer’s disease: prevalence and impact 

  26. J. Neuropsychiatry Clin. Neurosci. Payne 10 440 1998 10.1176/jnp.10.4.440 Relationship of cognitive and functional impairment to depressive features in Alzheimer’s disease and other dementias 

  27. Arch. Gen. Psychiatry Ownby 63 530 2006 10.1001/archpsyc.63.5.530 Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis 

  28. Brain Res. Rev. Frisardi 67 344 2011 10.1016/j.brainresrev.2011.04.003 Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship 

  29. Eur. J. Pharmacol. Caraci 626 64 2010 10.1016/j.ejphar.2009.10.022 Depression and Alzheimer's disease: neurobiological links and common pharmacological targets 

  30. Brain Behav. Immun. Santos 55 151 2016 10.1016/j.bbi.2015.11.011 Microglial dysfunction connects depression and Alzheimer’s disease 

  31. Experientia Pletscher 47 4 1991 10.1007/BF02041242 The discovery of antidepressants: a winding path 

  32. Indian J. Psychiatry Ramachandraih 53 180 2011 10.4103/0019-5545.82567 Antidepressants: from MAOIs to SSRIs and more 

  33. Neurotoxicology Youdim 25 243 2004 10.1016/S0161-813X(03)00103-7 Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation 

  34. Eur. J. Clin. Pharmacol. Palm 3 82 1971 10.1007/BF00619299 Quantitation of irreversible inhibition of monoamine oxidase in man 

  35. J. Am. Chem. Soc. Lee 136 299 2014 10.1021/ja409801p Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease 

  36. Proc. Natl. Acad. Sci. U. S. A. Choi 107 21990 2010 10.1073/pnas.1006091107 Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity 

  37. J. Am. Chem. Soc. Derrick 137 14785 2015 10.1021/jacs.5b10043 A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: in vitro and in vivo efficacy and molecular mechanisms 

  38. J. Am. Chem. Soc. Hindo 131 16663 2009 10.1021/ja907045h Small molecule modulators of copper-induced Aβ aggregation 

  39. Chem. Eur. J. Lee 23 2706 2017 10.1002/chem.201605401 Structural and mechanistic insights into development of chemical tools to control individual and inter-related pathological features in Alzheimer's disease 

  40. Chem. Sci. Beck 6 1879 2015 10.1039/C4SC03239J A rationally designed small molecule for identifying an in vivo link between metal-amyloid-β complexes and the pathogenesis of Alzheimer’s disease 

  41. Spermatogenesis Mruk 1 121 2011 10.4161/spmg.1.2.16606 Enhanced chemiluminescence (ECL) for routine immunoblotting. An inexpensive alternative to commercially available kits 

  42. J. Am. Chem. Soc. Barclay 106 2479 1984 10.1021/ja00320a066 Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants 

  43. Biochemistry Maheshwari 49 10371 2010 10.1021/bi101249p Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro 

  44. Synthesis Kawase 46 455 2014 10.1055/s-0033-1340484 Reductive alkylation of hydrazine derivatives with α-picoline-borane and its applications to the syntheses of useful compounds related to active pharmaceutical ingredients 

  45. Chem. Sci. Yi 12 2456 2021 10.1039/D0SC04366D Impact of sphingosine and acetylsphigosines on the aggregaiton and toxicity of metal-free and metal-treated amyloid-β 

  46. Chem. Commun. Yi 55 5847 2019 10.1039/C9CC01005J Tunable regulatory activities of 1,10-phenanthroline derivatives towards acid sphingomyelinase and Zn(II)-amyloid-β 

  47. ACS Chem. Neurosci. Han 9 800 2018 10.1021/acschemneuro.7b00454 Tuning structures and properties for developing novel chemical tools toward distinct pathogenic elements in Alzheimer’s disease 

  48. Chem. Eur. J. Kang 23 1645 2017 10.1002/chem.201604751 An iridium(III) complex as a photoactivatable tool for oxidation of amyloidogenic peptides with subsequent modulation of peptide aggregation 

  49. Biochemistry Smith 46 2881 2007 10.1021/bi0620961 Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-β peptide 

  50. J. Biol. Chem. Raman 280 16157 2005 10.1074/jbc.M500309200 Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid β peptide 

  51. Proc. Natl. Acad. Sci. U. S. A. Han 117 5160 2020 10.1073/pnas.1916944117 Mechanistic approaches for chemically modifying the coordination sphere of copper-amyloid-β complexes 

  52. Inorg. Chem. Front. Kim 7 4222 2020 10.1039/D0QI00791A Reactivities of cyclam derivatives with metal-amyloid-β 

  53. Free Radic. Biol. Med. Forrest 16 675 1994 10.1016/0891-5849(94)90182-1 Oxidative stress-induced apoptosis prevented by Trolox 

  54. J. Am. Chem. Soc. Kim 142 8183 2020 10.1021/jacs.9b13100 Minimalistic principles for designing small molecules with multiple reactivities against pathological factors in dementia 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로